Humalog

Lilly delivers upbeat earnings forecast for 2013

Current products such as Alimta and Cymbalta, as well as insulin product Humalog (insulin lispro) and Cialis (tadalafil) for erectile dysfunction, will support growth this year, said Lilly, as will expanded ... Humalog's $1.4bn in sales are also at risk

What Makes a Brand Iconic?

HUMALOG. When it first launched in '96, Humalog was the wunderkind of biotechnology. ... Humalog underwent a brand repositioning and refresh to create a new attitude towards insulin.

Lilly launches branded app for emergency diabetes medicine

Although Glucagon is rarely needed, and as such is far from a headline product within Lilly's portfolio, diabetes is an important area for the company and its Humalog insulin was

Lilly’s income drops 5 per cent

The insulin, Humalog, also achieved high growth, with revenue up 20 per cent.

Profits down for Eli Lilly

Cymbalta (duloxetine) for depression; Alimta (pemetrexed) for non-small cell lung cancer, and type 1 diabetes treatment Humalog (insulin lispro) also had strong quarters with double digit growth.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 [ Next 5 results ]